BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2245819)

  • 1. Bifemelane hydrochloride reduces plasma beta-endorphin-like immunoreactivity levels in rats.
    Mitsuma T; Hirooka Y; Yuasa K; Nogimori T
    Exp Clin Endocrinol; 1990 Aug; 95(3):301-5. PubMed ID: 2245819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of histamine and its blockers on plasma beta-endorphin-like immunoreactivity in rats.
    Mitsuma T; De Heng S; Nogimori T; Chaya M; Hirooka Y; Ohtake K
    Endocrinol Exp; 1987 Jun; 21(2):95-102. PubMed ID: 2956084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrotropin-releasing hormone reduces the plasma levels of beta-endorphin-like immunoreactivity in rats.
    Mitsuma T; Nogimori T; Sun DH; Chaya M
    Exp Clin Endocrinol; 1987 Mar; 89(1):55-60. PubMed ID: 2954835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium hopantenate, a GABA agonist, induces elevation of plasma beta-endorphin-like immunoreactivity levels in rats.
    Mitsuma T; Sun DH; Nogimori T; Chaya M; Ohtake K; Hirooka Y
    Exp Clin Endocrinol; 1987 Apr; 89(2):181-7. PubMed ID: 2956119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of eel calcitonin on plasma beta-endorphin-like immunoreactivity levels in rats.
    Mitsuma T; Hirooka Y; Nomura A; Okamoto H; Nogimori T
    Endocrinol Exp; 1988 Jun; 22(2):107-12. PubMed ID: 2970383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenergic control of immunoreactive beta-endorphin release from the pituitary of the rat: in vitro and in vivo studies.
    Pettibone DJ; Mueller GP
    J Pharmacol Exp Ther; 1982 Jul; 222(1):103-8. PubMed ID: 6283065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of bifemelane hydrochloride and indeloxazine hydrochloride on scopolamine hydrobromide-induced impairment in radial maze performance.
    Ogawa N; Haba K; Sora YH; Higashida A; Sato H; Ogawa S
    Clin Ther; 1988; 10(6):704-11. PubMed ID: 3219685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raloxifene analog LY 117018 effects on central and peripheral beta-endorphin.
    Genazzani AR; Bernardi F; Stomati M; Rubino S; Giardina L; Luisi S; Monteleone P; Genazzani AD; Luisi M; Petraglia F
    Gynecol Endocrinol; 1999 Aug; 13(4):249-58. PubMed ID: 10533160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in beta-endorphin-like-immunoreactivity in the blood plasma of ewes during estrous cycle and in anestrous ewes under stress condition.
    Ostrowska A; Przekop F; Boguszewskí B
    Exp Clin Endocrinol; 1990 Aug; 95(3):307-14. PubMed ID: 2245820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticonvulsant effects of bifemelane hydrochloride on kindled seizures from the amygdala and hippocampus in rats].
    Nakamura Y; Morimoto K; Moriwake T; Okamoto M; Sato K; Hirayasu Y; Katayama K; Onishi M; Otsuki S
    Yakubutsu Seishin Kodo; 1989 Jun; 9(2):241-4. PubMed ID: 2816097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tibolone administration on central and peripheral levels of allopregnanolone and beta-endorphin in female rats.
    Genazzani AR; Bernardi F; Pluchino N; Giretti MS; Begliuomini S; Casarosa E; Luisi M; Kloosterboer HJ
    Menopause; 2006; 13(1):57-64. PubMed ID: 16607099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phencyclidine increased release of beta-endorphin from anterior lobe of the pituitary.
    Contreras PC; Jacobson AE; Rice KC; Farah JM
    J Pharmacol Exp Ther; 1991 Sep; 258(3):837-41. PubMed ID: 1653842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-Endorphin-like immunoreactivity in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and -abstinent rats.
    Bhargava HN; Matwyshyn GA; Rattan AK; Koo KL; Tejwani GA
    J Pharmacol Exp Ther; 1994 Feb; 268(2):856-61. PubMed ID: 8113998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of bifemelane on central dopaminergic and cholinergic systems in rats].
    Ushijima I; Tsutsumi C; Hara T; Soeda K; Kishimoto O; Kaneyuki H; Mizuki Y; Yamada M
    Yakubutsu Seishin Kodo; 1988 Dec; 8(4):463-70. PubMed ID: 2907957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stimulatory effect of a non-opiate beta-endorphin fragment on arginine-vasopressin release in rats.
    Laczi F; Sykes JE; Wiegant VM; de Wied D
    Acta Med Hung; 1984; 41(1):55-63. PubMed ID: 6330664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-casomorphin inhibits thyrotropin secretion in rats.
    Mitsuma T; Nogimori T; Chaya M
    Exp Clin Endocrinol; 1984 Dec; 84(3):324-30. PubMed ID: 6441729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dehydroepiandrosterone on central and peripheral levels of allopregnanolone and beta-endorphin.
    Bernardi F; Casarosa E; Pluchino N; Palumbo M; Genazzani AD; Luisi S; Genazzani AR
    Fertil Steril; 2005 Apr; 83 Suppl 1():1161-8. PubMed ID: 15831289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro effects of angiotensin II on the release of beta-endorphin-like immunoreactivity.
    Matsumura M; Inoue S; Yamanoi A; Chikamori K; Saito S
    Endocrinol Jpn; 1985 Apr; 32(2):233-40. PubMed ID: 2931275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that a serotonergic mechanism stimulates the secretion of pituitary beta-endorphin-like immunoreactivity in the rat.
    Sapun DI; Farah JM; Mueller GP
    Endocrinology; 1981 Aug; 109(2):421-6. PubMed ID: 6265189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vivo and in vitro effects of histamine on the release of beta-endorphin-like immunoreactivity].
    Inoue S; Matsumura M
    Nihon Naibunpi Gakkai Zasshi; 1986 Mar; 62(3):158-68. PubMed ID: 2872089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.